MiNK Therapeutics, Inc.·4

Sep 19, 7:05 PM ET

Behner Peter 4

4 · MiNK Therapeutics, Inc. · Filed Sep 19, 2022

Insider Transaction Report

Form 4
Period: 2022-09-15
Behner Peter
Director
Transactions
  • Award

    Common Stock

    2022-09-15$2.62/sh+11,737$30,75111,737 total
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION